Get the Stockscreener App
16.11
0.00%
0.00
Adma Biologics Inc stock is traded at $16.11, with a volume of 3.44M.
It is up +0.00% in the last 24 hours and down -3.88% over the past month.
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
See More
Previous Close:
$16.11
Open:
$15.99
24h Volume:
3.44M
Relative Volume:
1.08
Market Cap:
$3.84B
Revenue:
$426.45M
Net Income/Loss:
$197.67M
P/E Ratio:
19.65
EPS:
0.82
Net Cash Flow:
$110.10M
1W Performance:
-4.51%
1M Performance:
-3.88%
6M Performance:
-12.92%
1Y Performance:
-8.73%
1-Day Range:
$15.73
$16.29
1-Week Range:
$15.73
$16.87
52-Week Range:
$14.62
$25.67
Adma Biologics Inc Stock (ADMA) Company Profile
Name
Adma Biologics Inc
Sector
Industry
Phone
(201) 478-5552
Address
C/O ADMA BIOLOGICS, INC., RAMSEY
Compare ADMA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
16.11 | 3.76B | 426.45M | 197.67M | 110.10M | 0.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-19-23 | Resumed | Raymond James | Strong Buy |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Nov-11-21 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-09-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-04-19 | Initiated | Jefferies | Buy |
| Apr-15-19 | Reiterated | H.C. Wainwright | Buy |
| Feb-07-19 | Resumed | H.C. Wainwright | Buy |
| Dec-11-17 | Reiterated | Maxim Group | Buy |
| Nov-14-17 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-23-17 | Upgrade | Maxim Group | Hold → Buy |
| Aug-01-16 | Downgrade | Maxim Group | Buy → Hold |
| Jul-25-16 | Reiterated | Maxim Group | Buy |
| May-13-15 | Reiterated | Maxim Group | Buy |
| Dec-08-14 | Initiated | Oppenheimer | Outperform |
| Dec-01-14 | Reiterated | Maxim Group | Buy |
View All
Adma Biologics Inc Stock (ADMA) Latest News
Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic? - sharewise.com
Bosun Asset Management LLC Lowers Holdings in ADMA Biologics Inc $ADMA - MarketBeat
PDT Partners LLC Takes Position in ADMA Biologics Inc $ADMA - MarketBeat
Ardsley Advisory Partners LP Invests $5.95 Million in ADMA Biologics Inc $ADMA - MarketBeat
Cubist Systematic Strategies LLC Grows Stock Holdings in ADMA Biologics Inc $ADMA - MarketBeat
How to read the order book for ADMA Biologics Inc.Market Activity Report & Advanced Swing Trade Entry Plans - Newser
Understanding ADMA Biologics Inc.’s price movementWeekly Stock Recap & Weekly High Return Forecasts - Newser
Does ADMA Biologics Inc. qualify in momentum factor screeningPortfolio Profit Report & Technical Entry and Exit Alerts - Newser
Does ADMA Biologics Inc. stock benefit from AI growth2025 Stock Rankings & Proven Capital Preservation Methods - خودرو بانک
Vident Advisory LLC Takes Position in ADMA Biologics Inc $ADMA - MarketBeat
Will ADMA Biologics Inc. stock go up soon2025 Institutional Moves & Consistent Growth Stock Picks - Newser
ADMA Biologics Inc. stock outlook for YEARFed Meeting & Safe Capital Investment Plans - Newser
ADMA Biologics Inc. stock volume spike explainedJuly 2025 Outlook & Weekly High Return Stock Opportunities - Newser
Will ADMA Biologics Inc. outperform its industry peersJuly 2025 Setups & Free Daily Entry Point Trade Alerts - khodrobank.com
Automated trading signals detected on ADMA Biologics Inc.Product Launch & Safe Entry Zone Tips - Newser
ADMA Biologics Inc. stock daily chart insightsGap Down & Community Driven Trade Alerts - Newser
Is ADMA Biologics Inc. stock heavily shorted2025 Bull vs Bear & High Accuracy Investment Signals - خودرو بانک
What is ADMA Biologics Inc. s P E ratio telling usPortfolio Performance Summary & Smart Swing Trading Alerts - خودرو بانک
Real time scanner hits for ADMA Biologics Inc. explainedTrade Analysis Summary & Long-Term Capital Growth Strategies - Newser
Can a trend reversal in ADMA Biologics Inc. lead to recoveryWeekly Investment Summary & AI Optimized Trade Strategies - Newser
HighTower Advisors LLC Sells 69,173 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Combining machine learning predictions for ADMA Biologics Inc.July 2025 Highlights & Weekly Breakout Opportunity Watchlist - Newser
Will ADMA Biologics Inc. continue its uptrendJuly 2025 Short Interest & Weekly Top Gainers Alerts - Newser
Driehaus Capital Management LLC Boosts Stock Position in ADMA Biologics Inc $ADMA - MarketBeat
Advanced analytics toolkit walkthrough for ADMA Biologics Inc.2025 Trading Volume Trends & Weekly High Return Stock Opportunities - Newser
Using Ichimoku Cloud for ADMA Biologics Inc. technicals2025 Market Overview & Low Risk Growth Stock Ideas - Newser
Full technical analysis of ADMA Biologics Inc. stockRate Hike & High Yield Equity Trading Tips - Newser
Statistical indicators supporting ADMA Biologics Inc.’s strength2025 Retail Activity & Daily Profit Focused Stock Screening - Newser
ADMA Biologics: Boosting Earnings with Higher Plasma Yield and Diversified Product Mix - AInvest
ADMA Biologics: Strong Product Mix, Growing Margins & Compelling Upside (NASDAQ:ADMA) - Seeking Alpha
Is ADMA Biologics Inc. reversing from oversold territoryEarnings Overview Report & Weekly Watchlist of Top Performers - Newser
Can you recover from losses in ADMA Biologics Inc.Exit Point & Intraday High Probability Setup Alerts - Newser
Chart based analysis of ADMA Biologics Inc. trendsWeekly Investment Report & Community Verified Swing Trade Signals - Newser
Rafferty Asset Management LLC Has $4.43 Million Position in ADMA Biologics Inc $ADMA - MarketBeat
Is ADMA Biologics Inc. stock poised for growthPortfolio Value Report & Safe Swing Trade Setups - Newser
Technical analysis overview for ADMA Biologics Inc. stockQuarterly Profit Review & Long Hold Capital Preservation Plans - Newser
ADMA Biologics Inc. stock chart pattern explainedJuly 2025 Earnings & Daily Market Momentum Tracking - Newser
Is ADMA Biologics Inc. forming a double bottomMarket Risk Report & Fast Gain Swing Alerts - خودرو بانک
Using economic indicators to assess ADMA Biologics Inc. potential2025 Market Trends & Weekly Market Pulse Updates - Newser
How moving averages guide ADMA Biologics Inc. tradingShare Buyback & Stock Portfolio Risk Management - Newser
Analyst Upgrade: What are ADMA Biologics Inc.’s technical support levels - خودرو بانک
Candlestick signals on ADMA Biologics Inc. stock todayProfit Target & Daily Oversold Stock Bounce Ideas - Newser
Tools to monitor ADMA Biologics Inc. recovery probabilityDollar Strength & Risk Managed Investment Strategies - Newser
Freedom Investment Management Inc. Makes New $303,000 Investment in ADMA Biologics Inc $ADMA - MarketBeat
Historical volatility pattern of ADMA Biologics Inc. visualizedQuarterly Market Summary & Verified Momentum Stock Alerts - Newser
Adma Biologics Inc Stock (ADMA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):